NCT05491031View on ClinicalTrials.gov

MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis

NARecruitingINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

April 25, 2023

Primary Completion Date

January 1, 2028

Study Completion Date

May 1, 2028

Conditions
Multiple SclerosisMagnetic Resonance Spectroscopy
Interventions
OTHER

magnetic resonance spectroscopy

Investigation of the association, in patients with multiple sclerosis, between MRI biomarker data at inclusion and progression of physical disability during follow-up (6, 12, 18 and 24 months) assessed by a composite endpoint EDSS plus (EDSS, 9HPT, T25FW)

Trial Locations (1)

86000

RECRUITING

PoitiersUH, Poitiers

All Listed Sponsors
lead

Poitiers University Hospital

OTHER